Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Testing effectiveness (Phase 2)WithdrawnNCT05157451
What this trial is testing

Y-90 Versus SBRT for Inoperable HCC

Who this might be right for
Hepatocellular CarcinomaStage I Hepatocellular Carcinoma AJCC v8Stage IA Hepatocellular Carcinoma AJCC v8+6 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06590246
What this trial is testing

Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd. 121
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515469
What this trial is testing

A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, an Anti-PD-1/Anti-CTLA-4 Bispecific Antibody, in Resectable Stage IB and IIA Hepatocellular Carcinoma With High Recurrence Risk

Who this might be right for
HCC - Hepatocellular CarcinomaIparomlimab and Tuvonralimab InjectionNeoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Early research (Phase 1)Study completedNCT00706576
What this trial is testing

Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor

Who this might be right for
Hepatocellular Cancer
University of Missouri-Columbia 14
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Looking for participantsNCT07478302
What this trial is testing

SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Unresectable Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 36
Testing effectiveness (Phase 2)UnknownNCT04503902
What this trial is testing

Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 46
Large-scale testing (Phase 3)Study completedNCT02109146
What this trial is testing

Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial Chemoembolization
Zhejiang University 332
Testing effectiveness (Phase 2)Ended earlyNCT04805788
What this trial is testing

Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaStage I Hepatocellular Carcinoma AJCC v8Stage II Hepatocellular Carcinoma AJCC v8+1 more
Mayo Clinic 9
Early research (Phase 1)Looking for participantsNCT06891742
What this trial is testing

Phase I Study of OriC902 in Treatment of Advanced HCC

Who this might be right for
HCC
Peking University 44
Early research (Phase 1)Study completedNCT01665937
What this trial is testing

STA-9090 in Patients With Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular Carcinoma
Massachusetts General Hospital 16
Early research (Phase 1)WithdrawnNCT01618253
What this trial is testing

Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatoma+1 more
Medical College of Wisconsin
Early research (Phase 1)WithdrawnNCT06217094
What this trial is testing

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Who this might be right for
Hepatocellular Carcinoma
University of Florida
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT06848556
What this trial is testing

Evaluate the Effect of Tirazamine on Primary Liver Cancer.

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Zhejiang Raygene Pharmaceuticals Co., Ltd 16
Early research (Phase 1)Study completedNCT00019630
What this trial is testing

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Soft Tissue SarcomaChildhood Liver CancerBone Cancer+2 more
National Cancer Institute (NCI)
Next Page